4.6 Article

Do worsening lung ultrasound scans identify severe COVID-19 trajectories?

Journal

FRONTIERS IN MEDICINE
Volume 9, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2022.1021929

Keywords

lung ultrasound; point-of-care lung ultrasound; COVID-19; severe COVID-19; cohort study

Funding

  1. Joint Program Executive Office (JPEO-EB) through the Office of the Assistant Secretary of Defense for Health Affairs [W911QY-20-9-0004]
  2. Johns Hopkins University School of Medicine COVID-19 Research Fund

Ask authors/readers for more resources

The study found that COVID-19 patients with ICU-level or fatal peak illness had higher mean lung ultrasound scores and lower percentage of lung fields with A-lines compared to those with less severe hospitalized illness, regardless of the duration of illness. However, there were no differences in the trajectories of mean lung ultrasound scores and percentage of lung fields with A-lines between severity groups. Therefore, serial lung ultrasound scans may not be useful in monitoring the progression of COVID-19 in hospitalized adults.
BackgroundWhile point-of-care ultrasound (POCUS) has been used to track worsening COVID-19 disease it is unclear if there are dynamic differences between severity trajectories. MethodsWe studied 12-lung zone protocol scans from 244 participants [with repeat scans obtained in 3 days (N = 114), 7 days (N = 53), and weekly (N = 9)] >= 18 years of age hospitalized for COVID-19 pneumonia. Differences in mean lung ultrasound (LUS) scores and percent of lung fields with A-lines over time were compared between peak severity levels (as defined by the WHO clinical progression scale) using linear mixed-effects models. ResultsMean LUS scores were elevated by 0.19 (p = 0.035) and A-lines were present in 14.7% fewer lung fields (p = 0.02) among those with ICU-level or fatal peak illness compared to less severe hospitalized illness, regardless of duration of illness. There were no differences between severity groups in the trajectories of mean LUS score 0.19 (p = 0.66) or percent A-lines (p = 0.40). DiscussionOur results do not support the use of serial LUS scans to monitor COVID-19 disease progression among hospitalized adults.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available